Intelligent Hemorrhage Control System with AI, IoT, and Blockchain Integration

A novel system integrating a stent graft device with AI-powered fluid pressure sensors, IoT-enabled wearable devices, blockchain-based data storage, and machine learning algorithms to provide real-time bleeding risk monitoring, optimized treatment protocols, and enhanced patient outcomes.

The original patent, 'Automated retrievable hemorrhage control system,' addressed the critical issue of catastrophic bleeding from large and medium-sized vessels. However, it lacked real-time monitoring capabilities, AI-driven insights, and secure data storage. The new inventive concept addresses these limitations by synergistically combining distinct technologies to create a more powerful and effective system.

The Intelligent Hemorrhage Control System comprises a stent graft device, an AI-powered fluid pressure sensor, an IoT-enabled wearable device, a blockchain-based data storage module, and a machine learning algorithm. The AI-powered sensor detects fluid pressure and communicates with the blockchain-based data storage module to record and analyze patient data. The IoT-enabled wearable device monitors patient vital signs and provides real-time feedback to medical personnel. The machine learning algorithm predicts bleeding risk and optimizes treatment protocols. The system enables real-time monitoring of bleeding risk, improved patient outcomes, and enhanced data security.

The new claims introduce a novel combination of AI, IoT, and blockchain technologies to create a more powerful and effective hemorrhage control system. The inventive step lies in the synergistic integration of these distinct technologies to provide real-time monitoring, optimized treatment protocols, and enhanced patient outcomes.

Alternative embodiments may include integrating the system with other medical devices, such as ultrasound or CT scanners, to provide a more comprehensive view of patient health. Variations may include using different types of sensors or machine learning algorithms to optimize system performance.

The Intelligent Hemorrhage Control System has significant commercial potential in the medical device industry, particularly in the fields of vascular surgery, emergency medicine, and critical care. The system's ability to provide real-time monitoring and optimized treatment protocols makes it an attractive solution for hospitals, clinics, and medical research institutions.